Posted by Michael Wonder on 16 Jan 2022
Global regulators discuss path towards regulatory alignment on response to Omicron variant
13 January 2022 - On 12 January, regulators from around the world discussed the global regulatory response to the COVID-19 Omicron variant during a workshop, co-chaired by the EMA and US FDA under the umbrella of the International Coalition of Medicines Regulatory Authorities.
The goal of the meeting was to review available evidence for the effectiveness of the approved COVID-19 vaccines against the Omicron variant and reach alignment on the key regulatory requirements to support development of a possible adapted vaccine.
